Cargando…
Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence
Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive loss of dopaminergic neurons, appearance of Lewy bodies and presence of neuroinflammation. No treatments currently exist to prevent PD or delay its progression, and dopaminergic substitution treatments just rel...
Autores principales: | Storelli, Elisa, Cassina, Niccolò, Rasini, Emanuela, Marino, Franca, Cosentino, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353825/ https://www.ncbi.nlm.nih.gov/pubmed/30733703 http://dx.doi.org/10.3389/fneur.2019.00013 |
Ejemplares similares
-
Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
por: Kustrimovic, Natasa, et al.
Publicado: (2018) -
The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases
por: Tabarkiewicz, Jacek, et al.
Publicado: (2015) -
Advances in the study of IL-17 in neurological diseases and mental disorders
por: Lu, Yu, et al.
Publicado: (2023) -
Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease
por: Kustrimovic, Natasa, et al.
Publicado: (2016) -
Th17/IL-17A Might Play a Protective Role in Chronic Lymphocytic Leukemia Immunity
por: Hus, Iwona, et al.
Publicado: (2013)